Skip to main content
. 2020 Feb 7;28(1):41–49. doi: 10.3727/096504019X15615433287579

Figure 1.

Figure 1

The expression levels of miR-122 in 15 pairs of human tissues (hepatocarcinoma and paracarcinoma tissues). (A) The miR-122 expression level had an average of 44% reduction in hepatocarcinoma tissues compared with paired paracarcinoma tissues. (B) The expression level of miR-122 transfected with miR-122 mimics or negative control in the SMMC7721 cells (p < 0.05). (C) The different miR-122 expression level of miR-122 antisense oligodeoxynucleotide (ASO) transfection and control group in the Hep3B cells (p < 0.05). *p < 0.05.